Article
Substitution of lysine-181 to aspartic acid in the third transmembrane region of the endothelin (ET) type B receptor selectively reduces its high-affinity binding with ET-3 peptide.
Journal of cardiovascular pharmacology - 1 Jan 1992
Mauzy C, Wu L H, Egloff A M, Mirzadegan T, Chung F Z
Abstract excerpt
In the G protein-coupled receptor family, a highly conserved aspartic acid located within the third transmembrane domain has been shown to be involved in ligand binding. Within the endothelin (ET) peptide receptor family, this aspartic acid has been replaced by a lysine. To assess the importance of this residue in ET binding, the lysine (position 181) of rat ET type B receptor was replaced by an aspartic acid....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
